...
首页> 外文期刊>Alzheimer disease and associated disorders >Alterations in Cholesterol and Ganglioside GM1 Content of Lipid Rafts in Platelets From Patients With Alzheimer Disease
【24h】

Alterations in Cholesterol and Ganglioside GM1 Content of Lipid Rafts in Platelets From Patients With Alzheimer Disease

机译:阿尔茨海默病患者血小板中脂质筏中胆固醇和神经节苷脂GM1含量的变化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to investigate the changes in the protein, cholesterol, and ganglioside GM1 content of lipid rafts in platelets from patients with Alzheimer disease (AD), and identify potential blood biomarkers of the disease. A total of 31 Chinese patients with AD and 31 aged-matched control subjects were selected. Lipid rafts were isolated from platelets using Optiprep gradient centrifugation. The protein content of lipid rafts was evaluated using Micro BCA assay, the cholesterol content using molecular probes, ganglioside GM1 content using colorimetry and dot-blotting analysis. The results showed that the cholesterol and ganglioside GM1 content of lipid rafts from platelets was significantly higher in patients with AD than aged-matched control subjects, whereas the protein content of lipid rafts did not show any differences between the 2 groups. These results indicate that the increases in the cholesterol and ganglioside GM1 content of lipid rafts from the platelets of patients with AD might serve as a biochemical adjunct to the clinical diagnosis of AD.
机译:这项研究的目的是调查阿尔茨海默病(AD)患者血小板中脂筏的蛋白质,胆固醇和神经节苷脂GM1含量的变化,并确定该疾病的潜在血液生物标志物。总共选择了31名中国AD患者和31名年龄匹配的对照受试者。使用Optiprep梯度离心从血小板中分离出脂质筏。使用Micro BCA分析评估脂质筏的蛋白质含量,使用分子探针评估胆固醇的含量,使用比色法和斑点印迹分析评估神经节苷脂GM1的含量。结果显示,AD患者血小板脂质筏中胆固醇和神经节苷脂GM1的含量显着高于老年匹配对照组,而两组脂质脂质中的蛋白质含量没有差异。这些结果表明,来自AD患者的血小板的脂质筏中胆固醇和神经节苷脂GM1含量的增加可能是AD临床诊断的生化辅助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号